Selpercatinib 2152628-33-4
1 Inquiries
2152628-33-4
Pharmaceutical Grade
99%
Zison
foil bag
2023-03-31
Avatrombopag,Lenvatinib,Safinamide mesylate,Axitinib
-
Product Description
-
Seller Information
-
Inquiry History
-
DescriptionBasic Info
-
Product Name:
Selpercatinib
Other Name:CPD2206;LOX-292;LOXO-292; LOXO292;LOXO 292;LOXO-292,Selpercatinib;Selpercatinib(LOXO-292);6-?(2-?Hydroxy-?2-?methylpropoxy)?-?4-?[6-?[6-?[(6-?methoxy-?3-?pyridinyl)?methyl]?-?3,?6-?diazabicyclo[3.1.1]?hept-?3-?yl]?-?3-?pyridinyl]?pyrazolo[1,?5-?a]?pyridine-?3-?carbonitrile;Pyrazolo[1,5-a]pyridine-3-carbonitrile, 6-(2-hydroxy-2-methylpropoxy)-4-[6-[6-[(6-methoxy-3-pyridinyl)methyl]-3,6-diazabicyclo[3.1.1]hept-3-yl]-3-pyridinyl]-;LOXO-292 USP/EP/BP
CAS No.:2152628-33-4
Molecular Formula:C29H31N7O3
InChIKeys:XIIOFHFUYBLOLW-UHFFFAOYSA-N
Molecular Weight:525.6
Exact Mass:525.24883788
EC Number:207-854-9
UNII:CEGM9YBNGD
NCI Thesaurus Code:C134987
Color/Form:White to off-white
ATC Code:L01EX22
Categories:
Characteristics-
Density:
1.36±0.1 g/cm3(Predicted)
Water Solubility:<1 mg/mL
PKA:14.00±0.29(Predicted)
Critical Temperature & Pressure:Store at -20°C
-
-
Seller Information
-
Business Type:
Manufactory
-
Main Products:
Avatrombopag,Lenvatinib,Safinamide mesylate,Axitinib
-
Location:
Room 410, Building 9, No. 2566, Century Avenue, Jinan, 250104, China
-
Payment Terms:
TT against copy of documents,L/C,TT against B/L draft before shipment,100% TT in advance
-
Average lead Time:
10
-
Total Annual Revenue:
$2.5 million-$5 million
-
Total Employees:
51-100
-
Year of Establishment:
2021
-
Certifications:
business license,ISO
-
-
Inquiry History1 Inquiries
Country Product Purchase Quantity Date Posted 
Pakistan
Selpercatinib
500 MG Jun 24, 2025 Post an enquiry for this product
